In relation to this, our comparative analysis of functional importance of different lines of PTEN modulation in B-cell lymphoma justifies the significance of the presence of endogenous PTEN in exerting enhanced drug sensitivity compared to the PTEN-deleted condition (Figure 2B). This evidence concerns the gene PTEN and B-cell non-Hodgkin lymphoma.